Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Siegler

Showing results (211-220 of 215) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 215 results.
Annals of Internal Medicine|October 3, 2000
Responding to intractable terminal sufferingD P Sulmasy, W A Ury, J C Ahronheim, et al.
Annals of Internal Medicine|October 3, 2000
Palliative treatment of last resort and assisted suicideD P Sulmasy, W A Ury, J C Ahronheim, et al.
Annals of Surgical Oncology|March 8, 2024
Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX TrialThorsten O Goetze, Alexander Reichart, Ulli S Bankstahl, et al.
Clinical Pharmacology and Therapeutics|December 17, 2016
Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation ProgramR P McKillip, B A Borden, P Galecki, et al.
Clinical Pharmacology and Therapeutics|April 12, 2017
Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug PrescribingP H O'Donnell, N Wadhwa, K Danahey, et al.
Pageof 22

Showing results (211-220 of 215) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 215 results.
Annals of Internal Medicine|October 3, 2000
Responding to intractable terminal sufferingD P Sulmasy, W A Ury, J C Ahronheim, et al.
Annals of Internal Medicine|October 3, 2000
Palliative treatment of last resort and assisted suicideD P Sulmasy, W A Ury, J C Ahronheim, et al.
Annals of Surgical Oncology|March 8, 2024
Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX TrialThorsten O Goetze, Alexander Reichart, Ulli S Bankstahl, et al.
Clinical Pharmacology and Therapeutics|December 17, 2016
Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation ProgramR P McKillip, B A Borden, P Galecki, et al.
Clinical Pharmacology and Therapeutics|April 12, 2017
Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug PrescribingP H O'Donnell, N Wadhwa, K Danahey, et al.
Pageof 22